Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen in Non-Metastatic Hepatocellular Carcinoma
NCT00493428Phase 2Withdrawn
- Sponsor
- University of Manitoba
- Start
- Jul 2007
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of baclofen in hepatocellular carcinoma (HCC), sponsored by University of Manitoba. Planned start Jul 2007; status: withdrawn.
02
Drugs
baclofen
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00493428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493428.